Abstract
Background In April 2020 we released the US COVID-19 Community Vulnerability Index (CCVI) to bring to life vulnerability to health, economic, and social impact of COVID-19 at the state, county, and census tract level. Here we describe the methodology, how vulnerability is distributed across the U.S., and assess the impact on vulnerable communities over the first year of the pandemic.
Methods The index combines 40 indicators into seven themes, drawing on both public and proprietary data. We associate timeseries of COVID-19 cases, deaths, test site access, and rental arrears with vulnerability.
Results Although overall COVID-19 vulnerability is concentrated in the South, the seven underlying themes show substantial spatial variability. As of May 13, 2021, the top-third of vulnerable counties have seen 21% more cases and 47% more deaths than the bottom-third of vulnerable counties, despite receiving 27% fewer tests (adjusted for population). Individual vulnerability themes vary over time in their relationship with mortality as the virus swept across the country. Over 20% of households in the top vulnerability tercile have fallen behind on rent. Poorer test site access for rural vulnerable populations early in the pandemic has since been alleviated.
Conclusion The CCVI captures greater risk of health and economic impact. It has enjoyed widespread use in response planning, and we share lessons learned about developing a data-driven tool in the midst of a fast-moving pandemic. The CCVI and an interactive data explorer are available at precisionforcovid.org/ccvi.
What is already known on this topic
What is already known on this topic
Various communities across the United States will experience the adverse effects of public health crises to different degrees of severity.
Composite indicators, such as the CDC Social Vulnerability Index, have proven to be valuable to policymakers by turning complex data sets into easily digestible and actionable information. However, the indicators within the Social Vulnerability Index do not fully contextualize the negative impacts spurred by the current pandemic.
What this study adds
What this study adds
The U.S. COVID-19 Community Vulnerability Index captures vulnerabilities spanning health, social, and economic dimensions that have been felt by every community in the US differently.
Vulnerable populations have experienced more cases and deaths, higher unemployment, and a lack of access to critical support such as testing sites.
Precision policies targeting vulnerable populations need to be designed and enacted to decrease the gap in negative consequences experienced in this and future pandemics, and the COVID-19 Community Vulnerability Index is a tool to highlight where and why these inequities occur.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
There was no research conducted on human subjects.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.